His main interests are clinical medicine, teaching, and clinical research.
Dr. Elkhashab was the first in Canada to established the FibroScan Program, which now serves patients in 8 locations around the GTA. Fibroscan is a novel non-invasive technology that has been gaining popularity for the evaluation of hepatic fibrosis in patients with chronic liver disease of different etiologies. It measures the degree of liver stiffness. The technology utilizes ultrasonic waves hence there is no radiation exposure. Fibroscan is a very useful tool for diagnosis of early cirrhosis. Confirmatory long term longitudinal studies are being done to confirm the validity of Fibroscan in monitoring of disease progression, screening for complications of cirrhosis such as esophageal varices and hepatocellular carcinoma and also screening for portal hypertension.